New observations on bone fragility with glucocorticoid treatment. Results from an in vivo animal model

Journal of Musculoskeletal Neuronal Interactions

Volumn 5, Issue 4, 2005, Pages 331-332

  Lane, Nancy E ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Medicine ^*  (United States)

Author keywords

Bone fragility; Glucocorticoids; Mice

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; GLUCOCORTICOID; PARATHYROID HORMONE;

ANIMAL MODEL; ARTICLE; BONE FRAGILITY; BONE MATRIX; BONE MINERAL; BONE STRENGTH; CELL DEATH; CORTICOSTEROID THERAPY; DRUG MECHANISM; FEMUR; IN VIVO STUDY; LUMBAR VERTEBRA; NONHUMAN; OSTEOCYTE; RAMAN SPECTROMETRY; TRABECULAR BONE; YOUNG MODULUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOMECHANICS; BONE AND BONES; GLUCOCORTICOIDS; MICE; PREDNISOLONE; SPECTRUM ANALYSIS, RAMAN;

EID: 33644528380     PISSN: 11087161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Lane NE. An Update on Glucocorticoid-induced Osteoporosis. Rheumatic Disease Clinics of North America, Lane NE (Guest Editor) 2001; 27:235-254.
2. Saag KG. Glucocorticoid-induced osteoporosis. Endocrinol Metab Clin North Am 2003; 32:135-157.
3. Cooper C, Coupland C, Mitchell M. Rheumatoid arthritis, corticosteroid therapy, and hip fracture. Ann Rheum Dis 1995; 54:49-52.
4. Van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C. Bone density threshold and other predictors of vertebral fractures in patients receiving oral glucocorticoid therapy. Arthritis Rheum 2003; 48:3224-3229.
5. Dempster D. Iliac crest biopsy: Bone histomorphometry in glucocorticoid-induced osteoporosis. J Bone Miner Res 1989; 4:137-141.
6. Dovio A, Perazzolo L, Ostella G, Ventura M, Termine A, Milano E, Bertolotto A, Angeli AJ. Immediate fall of bone formation and transient increase of bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis. Clin Endocrinol Metab 2004; 89:4923-4928.
7. Manolagas SC, Weinstein RS. New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res 1999; 14:1061-1066.
8. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. J Clin Invest 1998; 102:274-282.
9. Lane NE, Sanchez S, Modin G, Genant HK, Pierini E, Arnaud CD. Parathyroid hormone treatment can reverse steroid osteoporosis: results of a randomized clinical trial. J Clin Invest 1998; 102:1627-1633.
10. Wallach S, Cohen S, Reid DM, Hosking DJ, Laan RF, Doherty SM, Maricic M, Rosen C, Brown J, Barton I, Chines AA. Effect of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy. Calcif Tissue Int 2000; 67:277-285.